Search results
1 day ago · Canopy Growth Corporation (CGC) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...
- A Look at Its Current valuation
- Aiming For Some Aggressive Targets
- Should You Take A Chance on Canopy Growth Stock?
Although Canopy Growth has lost a large chunk of its value, it has historically traded at high premiums. And that's why it is important to put its recent decline into context. Here is how it compares to rivals Aurora Cannabis, HEXO, and Tilray in terms of price-to-sales (P/S) ratios. CGC PS Ratio data by YCharts The stock has traded at a high multi...
When the company released its fiscal Q3 numbers, it included some medium-term financial targets that -- if it achieves them -- will be downright impressive. Canopy projects that in the second half of its fiscal 2022 (which began in April), it will post positive adjusted EBITDA. It also says that from fiscal 2022 through fiscal 2024, its net revenue...
Canopy Growth is a risky investment because it is far from a cheap pot stock, and it has created some high expectations for its future. If it achieves all of its medium-term targets, it could definitely produce some exceptional returns for shareholders. But that's a big "if." As an investor, I'm wary when it comes to companies that make projections...
- David Jagielski
Jun 27, 2023 · The correction in numbers led to a $10 million decrease in net revenue for the year, and $14 million decrease in net revenue for the last nine months ending on Dec. 31, 2022. Its other revenue sources from cannabis also came in lower. Net revenue for Canopy Growth stock was down 14% to $88 million, with its adjusted loss reaching $96 million.
- Amy Legate-Wolfe
1 day ago · Canopy Growth is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade. Conclusion
Jun 26, 2024 · However, in the fiscal fourth quarter (Q4) of 2024, Canopy Growth increased its sales by just 7% year over year to $72.8 million. While Canopy has narrowed its losses, its cash outflow totalled ...
Oct 5, 2024 · It’s worth noting that Canopy Growth stock traded at lows of $2.76 in mid-March 2024. With the news of possible reclassification of cannabis as a Schedule III drug, CGC stock skyrocketed to $14. ...
People also ask
Did Canopy Growth Stock just hit 52-week lows?
Why is canopy stock a bearish stock?
How did Canopy Growth perform in Q4 2024?
What happened to Canopy Growth (CGC) stock?
Is Canopy Growth a good stock to buy?
Will Canopy Growth make big investments?
3 days ago · Canopy Growth posts wider loss as revenue falls. Canopy Growth Corp. CGC, +8.29% WEED, +7.60% said Friday its first-quarter loss widened to C$127.14 million ($92.7 million), or C$1.60 a share, from C$41.86 million, or C$0.69 a share in the year-ago ... 2 months ago - Market Watch.
